Agenus (AGEN) Acquisitions (2014 - 2022)

Agenus (AGEN) posted quarterly Acquisitions of -$735000.0 for Q4 2022, down 213.08% quarter-over-quarter from $650000.0 in Q2 2022.

Analysis

Agenus (AGEN) Acquisitions (2014 - 2022) Analysis & Trends

Agenus' Acquisitions history runs 4 years deep, the most recent figure standing at -$735000.0 for Q4 2022.

In Q4 2022, Acquisitions changed N/A year-over-year to -$735000.0; the TTM figure through Dec 2022 stood at $2.9 million (changed N/A YoY), while the FY2022 annual figure was $2.9 million, changed N/A from the prior year.
Acquisitions for Q4 2022 stood at -$735000.0, down from $650000.0 in the prior quarter.
The five-year high for Acquisitions was $3.0 million in Q1 2022, with the low at -$735000.0 in Q4 2022.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Vertex Pharmaceuticals	138.92 Bn	131.07 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.55 Bn	77.56 Bn	3.93 Bn	-
3	Argenx Se	63.55 Bn	58.37 Bn	1.37 Bn	-
4	Moderna	58.26 Bn	53.13 Bn	52.00 Mn	-
5	Revolution Medicines	44.08 Bn	44.08 Bn	-	-
6	BeOne Medicines	39.98 Bn	34.89 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.32 Bn	32.01 Bn	992.69 Mn	-
8	Royalty Pharma	28.42 Bn	27.59 Bn	-	-
9	Insmed	27.41 Bn	26.25 Bn	358.27 Mn	-
10	Agenus	343.93 Mn	343.93 Mn	34.52 Mn	-

Historic Data

Download Data